Dr. Mimi Roy

BioMarin Pharmaceutical Inc.

Gene therapy, AI and mass spec: Mimi Roy discusses rare disease research in Silicon Valley

Join SelectScience® CEO, Kerry Parker, as she speaks to Dr. Mimi Roy who is working at the cutting edge of developing gene therapies in rare diseases. During this podcast discussion, Roy shares how gene therapies and viral vectors work and why AI and mass spectrometry are accelerating science in this field. Roy also discusses her perspectives on time management, her outlook on teamwork, and how the future of science is a multidisciplinary and human endeavor. After beginning her academic career in India, Roy embarked on a journey that led her to Sydney, Australia, and eventually, the United States, where she pursued her Ph.D. in Chemistry at Princeton University and then a postdoctoral research position at the Scripps Research Institute. Roy then discovered the world of start-ups and biopharmaceuticals and never looked back.

Explore more advances in biopharma in our dedicated special feature: https://www.selectscience.net/accelerating-science/biopharma



LIKE 1
Dr. Mimi Roy
Health Sciences Virtual Summit Biopharma

Dr. Mimi Roy

Biography

Senior Director, BioMarin Pharmaceutical Inc. More
Follow Mimi

Dr. Mimi Roy

BioMarin Pharmaceutical Inc.

Mimi Roy is Senior Director, Analytical Chemistry at BioMarin since November 2015. Her primary interests are scientific management and drug development (protein engineering, CMC and translation sciences) with a focus on protein characterization, high-end molecular analytics including mass spectrometry and NMR. In 2014 she founded iON Bioservices, an analytical services & consulting firm, and co-founded SensiBrace Technologies - obtaining a patent on a device to address carpal tunnel syndrome, a condition she suffers from. Previously she served as the US Site-Head of Caprion Inc. with oversight of science and sales, and as Director of Analytics at Sutro Biopharma. Mimi has a B.Sc. (Honours) from St. Stephens College, New Delhi and a M.S. from University of Sydney in Biochemistry. She completed a Ph.D. in Chemistry from Princeton University in 1998 specializing in Protein Design and Characterization, followed by a post-doctoral fellowship in DNA Design with Peter Schultz, Professor, CEO & President, The Scripps Research Institute, La Jolla. Mimi lives in San Rafael, California, and likes to spend her spare time with her family, practice yoga and sing.